Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$788M |
| 2 |
Netflix
NFLX
|
+$687M |
| 3 |
UnitedHealth
UNH
|
+$638M |
| 4 |
Trade Desk
TTD
|
+$513M |
| 5 |
Home Depot
HD
|
+$374M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.12B |
| 2 |
Tesla
TSLA
|
+$717M |
| 3 |
Uber
UBER
|
+$656M |
| 4 |
argenx
ARGX
|
+$579M |
| 5 |
Eli Lilly
LLY
|
+$473M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.7% |
| 2 | Consumer Discretionary | 19.7% |
| 3 | Healthcare | 12.45% |
| 4 | Communication Services | 10.26% |
| 5 | Financials | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MAG
426
DELISTED
MAG Silver
MAG
| $5.13M | ﹤0.01% |
492,536
-1,116
| -0.2% | -$11.9K |
|
427
Service Corp International
SCI
$11.7B
| $4.61M | ﹤0.01% |
67,334
-11,478
| -15% | -$691K |
|
428
Canadian Pacific Kansas City
CP
$79.7B
| $4.58M | ﹤0.01% |
57,878
+12,036
| +26% | +$881K |
|
429
James Hardie Industries
JHX
$16.5B
| $4.53M | ﹤0.01% |
+117,206
| New | +$3.52M |
|
430
Lifezone Metals
LZM
$336M
| $4.35M | ﹤0.01% |
+481,650
| New | +$4.63M |
|
431
Stantec
STN
$8.28B
| $4.06M | ﹤0.01% |
+50,524
| New | +$3.5M |
|
432
Enphase Energy
ENPH
$5.52B
| $4.03M | ﹤0.01% |
30,480
-5,737
| -16% | -$608K |
|
433
CSX Corp
CSX
$94.5B
| $3.98M | ﹤0.01% |
114,675
+13,159
| +13% | +$419K |
|
434
Exelixis
EXEL
$14.1B
| $3.94M | ﹤0.01% |
164,200
+815
| +0.5% | +$17.7K |
|
435
Insmed
INSM
$21.4B
| $3.74M | ﹤0.01% |
+120,831
| New | +$3.13M |
|
436
Synopsys
SNPS
$77.3B
| $3.69M | ﹤0.01% |
7,172
+517
| +8% | +$264K |
|
437
iShares MSCI ACWI ex US ETF
ACWX
$11.7B
| $3.64M | ﹤0.01% |
71,367
-18,982
| -21% | -$914K |
|
438
McCormick & Company Non-Voting
MKC
$14B
| $3.45M | ﹤0.01% |
50,399
-8,573
| -15% | -$561K |
|
439
TXO Partners LP
TXO
$717M
| $3.38M | ﹤0.01% |
185,985
-3,377
| -2% | -$63.8K |
|
|
LBPH
440
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $2.9M | ﹤0.01% |
+480,828
| New | +$2.4M |
|
441
Apogee Therapeutics
APGE
$10.1B
| $2.9M | ﹤0.01% |
+103,744
| New | +$2.08M |
|
|
FUSN
442
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $2.89M | ﹤0.01% |
+301,020
| New | +$1.46M |
|
443
Coca-Cola
KO
$372B
| $2.7M | ﹤0.01% |
45,816
-610
| -1% | -$34.6K |
|
444
Dyne Therapeutics
DYN
$4.85B
| $2.7M | ﹤0.01% |
+202,871
| New | +$1.98M |
|
|
ALPN
445
DELISTED
Alpine Immune Sciences Inc
ALPN
| $2.69M | ﹤0.01% |
+141,095
| New | +$1.96M |
|
446
Scholar Rock
SRRK
$5.73B
| $2.58M | ﹤0.01% |
+137,049
| New | +$1.7M |
|
447
Lockheed Martin
LMT
$136B
| $2.56M | ﹤0.01% |
5,639
-8,939
| -61% | -$3.96M |
|
448
Disc Medicine
IRON
$2.99B
| $2.49M | ﹤0.01% |
+43,031
| New | +$2.2M |
|
|
TE
449
T1 Energy
TE
$1.52B
| $2.42M | ﹤0.01% |
1,293,137
-53,206
| -4% | -$144K |
|
450
Rambus
RMBS
$10.9B
| $2.34M | ﹤0.01% |
34,331
+5,129
| +18% | +$320K |
|
Similar funds
Jennison Associates's Q4 2023 Portfolio in Review
As of Q4 2023, Jennison Associates held 638 positions worth $134B, up 14% from $118B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Jennison Associates's Q4 2023 filing shows 77 new, 236 increased, 267 reduced and 55 closed positions. Its largest new stake was Boeing: 3,684,483 shares worth $960M. The largest sale was NVIDIA, an estimated $2.12B.
By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 37% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Jennison Associates's largest Q4 2023 buy was Boeing: 3,684,483 shares worth $960M.
- Jennison Associates added most to Netflix in Q4 2023, an estimated $687M increase.
- Jennison Associates's biggest Q4 2023 reduction was NVIDIA, cutting an estimated $2.12B.
- Jennison Associates fully exited Ulta Beauty in Q4 2023, selling an estimated $452M.
- Jennison Associates's ten largest holdings make up 40% of its $134B portfolio in Q4 2023.
- Jennison Associates opened 77 new positions and closed 55 in Q4 2023.
- Jennison Associates's portfolio value rose 14% quarter-over-quarter to $134B.
Based on Jennison Associates's 13F filing for Q4 2023, filed 1 Feb 2024.